INS and Insulin resistance: There is also growing evidence that anti-TNF-α biological drugs used to treat rheumatoid arthritis (RA) can improve insulin sensitivity and reduce insulin resistance in RA patients, raising the possibility that targeting proinflammatory pathways may also have therapeutic benefits in T2DM patients [49].